|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.68 HKD | +3.19% |
|
+3.12% | +7.12% |
| Capitalization | 117B 135B 17.24B 14.77B 13.51B 12.79B 23.68B 1,649B 23.87B 161B 62.61B 783B 64.71B 63.33B 2,727B | P/E ratio 2026 * |
21.4x | P/E ratio 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise value | 106B 123B 15.67B 13.42B 12.27B 11.62B 21.52B 1,498B 21.69B 146B 56.89B 712B 58.8B 57.54B 2,478B | EV / Sales 2026 * |
4.22x | EV / Sales 2027 * | 3.51x |
| Free-Float |
90.02% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: WuXi Biologics (Cayman) Inc.
| 1 day | +3.19% | ||
| 1 week | +3.12% | ||
| Current month | +1.94% | ||
| 1 month | -8.97% | ||
| 3 months | -16.84% | ||
| 6 months | +4.08% | ||
| Current year | +7.12% |
| 1 week | 32.02 |  | 34.7 |
| 1 month | 32.02 | | 37.72 |
| Current year | 30.94 | | 44 |
| 1 year | 22.95 | | 44 |
| 3 years | 10.14 | | 52.45 |
| 5 years | 10.14 | | 148 |
| 10 years | 8.33 | | 148 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 54 | 01/01/2016 |
Ming Tu
DFI | Director of Finance/CFO | 56 | 23/08/2021 |
Xuejun Gu
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Li
CHM | Chairman | 59 | 01/02/2014 |
Zhi Sheng Chen
BRD | Director/Board Member | 54 | 01/02/2014 |
Yan Ling Cao
BRD | Director/Board Member | 42 | 01/05/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.19% | +3.12% | +41.22% | -27.18% | 17.24B | |
| +0.52% | +4.03% | +43.64% | +85.93% | 50.39B | |
| -5.43% | -7.43% | +68.79% | +55.56% | 46.03B | |
| -2.01% | +10.11% | +76.22% | +517.30% | 25.06B | |
| -0.26% | -1.11% | -0.10% | -12.59% | 23.26B | |
| -1.66% | -4.24% | +29.99% | -41.30% | 16.15B | |
| -2.91% | -10.30% | +47.85% | +186.19% | 14.56B | |
| -3.46% | +5.77% | -20.26% | +954.65% | 14.08B | |
| +0.41% | -2.37% | +40.93% | - | 12.94B | |
| -0.37% | +10.58% | +14.45% | +166.42% | 12.84B | |
| Average | -1.20% | +0.38% | +34.27% | +209.44% | 23.26B | |
| Weighted average by Cap. | -1.47% | +0.59% | +41.26% | +167.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.22B 29.11B 3.72B 3.18B 2.91B 2.76B 5.1B 355B 5.15B 34.75B 13.5B 169B 13.95B 13.65B 588B | 29.43B 33.98B 4.34B 3.72B 3.4B 3.22B 5.96B 415B 6.01B 40.55B 15.75B 197B 16.28B 15.93B 686B |
| Net income | 5.49B 6.34B 809M 693M 634M 600M 1.11B 77.36B 1.12B 7.56B 2.94B 36.76B 3.04B 2.97B 128B | 6.64B 7.67B 979M 839M 767M 726M 1.34B 93.58B 1.36B 9.15B 3.55B 44.47B 3.67B 3.59B 155B |
| Net Debt | -10.69B -12.34B -1.58B -1.35B -1.23B -1.17B -2.16B -151B -2.18B -14.73B -5.72B -71.6B -5.91B -5.79B -249B | -13.68B -15.79B -2.02B -1.73B -1.58B -1.5B -2.77B -193B -2.79B -18.85B -7.32B -91.61B -7.57B -7.41B -319B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 33.68 $ | +3.19% | 35,563,543 |
| 14/05/26 | 32.64 $ | -3.60% | 26,986,420 |
| 13/05/26 | 33.86 $ | +0.47% | 19,669,180 |
| 12/05/26 | 33.70 $ | +1.94% | 22,628,880 |
| 11/05/26 | 33.06 $ | +1.22% | 22,588,860 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2269 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition